bioRN News
BioM Biotech Cluster Development GmbH, bioRN Life Science Cluster and ESMT Berlin announced the establishment of a Unified Hub for Healthcare Innovation. Through this alliance, the two biotech cluster organizations and DEEP – Institute for Deep Tech Innovation at ESMT will collaborate strategically to reinforce Germany’s position as a leading hub for translating scientific breakthroughs […]
read more
Member2Member: Where expertise meets the community
Every company in the bioRN network has a story to tell. More importantly, every company has knowledge that can help others move faster, avoid mistakes and spark new collaborations. That is the idea behind bioRN’s Member2Member series. Instead of traditional company presentations, Member2Member opens the doors to our member organisations and puts their expertise centre […]
read more
GeneNovate® 2026: Heidelberger Forschende stärken unternehmerisches Denken für die nächste Generation von Gen- und Zelltherapien
Heidelberg, Juni 2026 – Mit dem Final Event von GeneNovate® am 25. Juni in der Münchner Residenz endet die dritte Runde des bundesweiten Entrepreneurship-Programms der Nationalen Strategie für gen- und zellbasierte Therapien (Nationale Strategie GCT). Im Rahmen der Abschlussveranstaltung präsentierten Wissenschaftlerinnen und Wissenschaftler aus ganz Deutschland ihre innovativen Geschäftsideen mit Potenzial für zukünftige Gesundheitslösungen und […]
read more
Presentation of the EY German Biotechnology Report 2026 in Heidelberg: Strong Innovation Ecosystems Are Key to Scaling Innovation
Heidelberg, 11 June 2026 – Germany continues to produce world-class science, breakthrough technologies and highly innovative biotechnology companies. However, the challenge is no longer generating innovation – it is creating the conditions that allow innovation to scale. This was one of the central messages emerging from the presentation of the EY German Biotechnology Report 2026, […]
read more
Wo Zukunft entsteht: Deutschlands „Innovationsmaschinenräume“ präsentieren sich auf der re:publica 2026
Wie kann aus wissenschaftlicher Forschung eine konkrete medizinische Therapie entstehen? Im Maschinenraum der Life Sciences leistet bioRN Life Science Cluster genau das: Unter anderem beim Thema Frauengesundheit Heidelberg, 30 April 2026: Frauen sterben früher und werden oft schlechter therapiert. Der Grund dafür: Die medizinische Forschung und Entwicklung waren lange Zeit überwiegend auf männliche Populationen ausgerichtet. […]
read more
Heidelberg und Mainz vereinbaren gemeinsame Innovationspartnerschaft
Stärkung der Biotech-Region Neckar-Rhein-Main Die Städte Heidelberg und Mainz wollen künftig eng zusammenarbeiten: Ihr Ziel ist es, die Region Neckar–Rhein–Main als internationale Innovations- und Biotech-Region weiterzuentwickeln. Dazu haben der Heidelberger Oberbürgermeister Eckart Würzner und der Mainzer Oberbürgermeister Nino Haase am Freitag, 24. April 2026, im Heidelberger Rathaus ein Memorandum of Understanding (MoU) unterzeichnet. An der […]
read more
PRECISEU launches Open Call to accelerate interregional innovation in personalised medicine
Across Europe, the conversation around personalised medicine is no longer about potential—it is about implementation. The challenge is not only scientific progress, but how to move innovation across regions, systems and stakeholders in a coordinated way. In this context, the PRECISEU project has launched its Open Call for Joint Interregional Projects (JIPs), opening on 13 […]
read more
Introducing our New Members – Q1 2026
We are pleased to introduce these new members and highlight the diverse capabilities they bring to our cluster! Looking forward to your active participation! Bioneer A/Shttps://bioneer.dk/Bioneer is an R&D-driven CRO and CDMO and a Danish government-approved RTO with 40 years of experience. The company supports biotech and pharma partners in drug discovery, early development, and […]
read more
BioMed X Advances Women’s Health Innovation at Inaugural XFem Labs Pitch & Connect Event – Joint Event with bioRN
Heidelberg, Germany, 17 February 2026 - BioMed X, a leading innovation hub for pharma headquartered in Heidelberg, hosted the first XFem Labs Pitch & Connect event on February 13th in Heidelberg, marking the official launch of XFem Labs, its new Women’s Health R&D Accelerator established with support from the Gates Foundation. The purpose of this initiative is to build a world-class women’s health […]
read more
